FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005920419> ?p ?o ?g. }

• W2005920419 endingPage "1125" @default.
• W2005920419 startingPage "1118" @default.
• W2005920419 abstract "Severe endotoxemia, a condition where microembolization and intravascular coagulation are thought to play important roles, was treated experimentally with prostacyclin (PGI(2)). In a study of 24 dogs, 8 control animals injected with 1.75 mg.kg(-1) of endotoxin died within 24 h. Six animals given intravenous aspirin 100 mg/kg, 30 min after endotoxin died. 9 of 10 dogs infused with 100 ng PGI(2).kg(-1).min(-1) for 3 h, given 30 min after the injection of endotoxin survived 24 h (P < 0.025). Injection of endotoxin resulted in a: (a) maximal 62% fall in mean arterial pressure (P < 0.001); (b) transient doubling of mean pulmonary arterial pressure (P < 0.001); (c) initial 70% drop in cardiac index (P < 0.001); (d) decline in blood platelets from 213,700 to 13,700/mm(3) (P < 0.001), and leukocytes from 7,719 to < 750/mm(3) (P < 0.001); (e) depressed urine output (P < 0.001); (f) 34% decrease in blood fibrinogen (P < 0.01) and an increase in fibrin degradation products > 50 mug/ml (P < 0.001); (g) fivefold increase in circulating cathepsin D titer (P < 0.005) and (h) increase in blood norepinephrine (P < 0.005), dopamine (P < 0.005), and epinephrine (P < 0.001). Aspirin treatment led to an increase in mean arterial pressure (P < 0.001) and mean pulmonary arterial pressure (P < 0.005), but cardiac index, urine flow, platelets, leukocytes, fibrin degradation products, and cathepsin D levels remained similar to untreated controls. After infusion of PGI(2) there was a: (a) prompt increase of cardiac index to base-line levels; (b) late increase in mean arterial pressure (P < 0.005) after the discontinuation of PGI(2) treatment (c) restoration of urine output; (d) increase in circulating platelets to levels still below base line but above untreated control animals (P < 0.05); (e) no effect on circulating leukocyte levels; (f) fall in fibrin degradation products to 11.2 mug/ml (P < 0.05); (g) decline in cathepsin D levels to values 60% lower than the untreated controls (P < 0.025); and (h) reduction in plasma norepinephrine levels to base line at 4 h (P < 0.005). Although the mode of PGI(2) action is not clear, it is effective in the treatment of experimental endotoxemia." @default.
• W2005920419 created "2016-06-24" @default.
• W2005920419 creator A5002837242 @default.
• W2005920419 creator A5003026401 @default.
• W2005920419 creator A5003279460 @default.
• W2005920419 creator A5013856846 @default.
• W2005920419 creator A5033746515 @default.
• W2005920419 creator A5083450587 @default.
• W2005920419 date "1981-04-01" @default.
• W2005920419 modified "2023-10-10" @default.
• W2005920419 title "Prostacyclin Reversal of Lethal Endotoxemia in Dogs" @default.
• W2005920419 cites W156046135 @default.
• W2005920419 cites W1577219339 @default.
• W2005920419 cites W1578086833 @default.
• W2005920419 cites W1775749144 @default.
• W2005920419 cites W1984509111 @default.
• W2005920419 cites W1989639531 @default.
• W2005920419 cites W2002341825 @default.
• W2005920419 cites W2016308205 @default.
• W2005920419 cites W2020381325 @default.
• W2005920419 cites W2027340185 @default.
• W2005920419 cites W2032009067 @default.
• W2005920419 cites W2049961089 @default.
• W2005920419 cites W2079790969 @default.
• W2005920419 cites W2103379524 @default.
• W2005920419 cites W2146800979 @default.
• W2005920419 cites W2153301997 @default.
• W2005920419 cites W2171505383 @default.
• W2005920419 cites W2259262868 @default.
• W2005920419 cites W2286834192 @default.
• W2005920419 cites W2331133957 @default.
• W2005920419 cites W2400204968 @default.
• W2005920419 cites W2400853614 @default.
• W2005920419 cites W2402763364 @default.
• W2005920419 cites W2404787418 @default.
• W2005920419 cites W2418502291 @default.
• W2005920419 cites W2435037183 @default.
• W2005920419 cites W2464919483 @default.
• W2005920419 cites W346513679 @default.
• W2005920419 cites W4301628400 @default.
• W2005920419 doi "https://doi.org/10.1172/jci110125" @default.
• W2005920419 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/370672" @default.
• W2005920419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7009654" @default.
• W2005920419 hasPublicationYear "1981" @default.
• W2005920419 type Work @default.
• W2005920419 sameAs 2005920419 @default.
• W2005920419 citedByCount "86" @default.
• W2005920419 countsByYear W20059204192014 @default.
• W2005920419 crossrefType "journal-article" @default.
• W2005920419 hasAuthorship W2005920419A5002837242 @default.
• W2005920419 hasAuthorship W2005920419A5003026401 @default.
• W2005920419 hasAuthorship W2005920419A5003279460 @default.
• W2005920419 hasAuthorship W2005920419A5013856846 @default.
• W2005920419 hasAuthorship W2005920419A5033746515 @default.
• W2005920419 hasAuthorship W2005920419A5083450587 @default.
• W2005920419 hasBestOaLocation W20059204191 @default.
• W2005920419 hasConcept C126322002 @default.
• W2005920419 hasConcept C134018914 @default.
• W2005920419 hasConcept C2775859304 @default.
• W2005920419 hasConcept C2776452961 @default.
• W2005920419 hasConcept C2777628954 @default.
• W2005920419 hasConcept C2777953023 @default.
• W2005920419 hasConcept C2779036427 @default.
• W2005920419 hasConcept C2781128415 @default.
• W2005920419 hasConcept C71924100 @default.
• W2005920419 hasConcept C84393581 @default.
• W2005920419 hasConcept C89560881 @default.
• W2005920419 hasConceptScore W2005920419C126322002 @default.
• W2005920419 hasConceptScore W2005920419C134018914 @default.
• W2005920419 hasConceptScore W2005920419C2775859304 @default.
• W2005920419 hasConceptScore W2005920419C2776452961 @default.
• W2005920419 hasConceptScore W2005920419C2777628954 @default.
• W2005920419 hasConceptScore W2005920419C2777953023 @default.
• W2005920419 hasConceptScore W2005920419C2779036427 @default.
• W2005920419 hasConceptScore W2005920419C2781128415 @default.
• W2005920419 hasConceptScore W2005920419C71924100 @default.
• W2005920419 hasConceptScore W2005920419C84393581 @default.
• W2005920419 hasConceptScore W2005920419C89560881 @default.
• W2005920419 hasIssue "4" @default.
• W2005920419 hasLocation W20059204191 @default.
• W2005920419 hasLocation W20059204192 @default.
• W2005920419 hasLocation W20059204193 @default.
• W2005920419 hasLocation W20059204194 @default.
• W2005920419 hasOpenAccess W2005920419 @default.
• W2005920419 hasPrimaryLocation W20059204191 @default.
• W2005920419 hasRelatedWork W1989464596 @default.
• W2005920419 hasRelatedWork W2026413826 @default.
• W2005920419 hasRelatedWork W2038512896 @default.
• W2005920419 hasRelatedWork W2044985824 @default.
• W2005920419 hasRelatedWork W2054777415 @default.
• W2005920419 hasRelatedWork W2153502661 @default.
• W2005920419 hasRelatedWork W2168282899 @default.
• W2005920419 hasRelatedWork W2460584456 @default.
• W2005920419 hasRelatedWork W3140773452 @default.
• W2005920419 hasRelatedWork W2189594703 @default.
• W2005920419 hasVolume "67" @default.
• W2005920419 isParatext "false" @default.
• W2005920419 isRetracted "false" @default.

• next